Loading... Please wait.

Perfil da Empresa

Principais Executivos
Chief Executive Officer Dave Marver
Vice President Global Clinical, Regulatory & Quality Erika Ross Ellison
Vice President Engineering Julien Camisani
Vice President Operations Bob Odell
Vice President Sales Mark Landman
Finance Director Amori Fraser
Head of Strategy & Corporate Development Alexandre Casteau
Director People & Culture Julie Crom
Vice President Legal Lorenzo Fanti
Fonte: Onward Medical N.V. - Última atualização: 20 Mar 2025
Números principais
Millenium 2023 2022 2021 2020 2019
Net sales 532 2.148 1.399 800 554
Income from ordinary activities 532 2.148 1.399 800 554
Operating income -35.463 -32.028 -28.532 -15.512 -10.772
Cost of financial indebtedness net 421 1.453 5.613 4.441 2.670
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income -36.181 -32.772 -34.314 -20.014 -13.483
Net income (Group share) -36.181 -32.772 -34.314 -20.014 -13.483
Fiscal year end 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards IFRS IFRS IFRS IFRS IFRS
Fonte: Cofisem - Última atualização: 24 Mar 2025
Informação Acionistas
Ottobock SE & Co. KGaA 10.1 %
EQT Life Sciences Group B.V. 8.4 %
INKEF Capital B.V. 8.2 %
Gimv Investments H&C Netherlands 2016 B.V. 7.2 %
Wellington Partners GmbH 4.2 %
Wellington Partners Nominee 7,62 %
Fonte: Onward Medical N.V. - Última atualização: 20 Mar 2025

Morada

Onward Medical N.V.

Schimmelt 2
NL-5611 ZX Eindhoven
Netherlands
Fonte: Onward Medical N.V. - Última atualização: 20 Mar 2025

Contacto

Fonte: Onward Medical N.V. - Última atualização: 20 Mar 2025